High Sensitivity Cardiac Troponin Assays - How to Implement them Successfully.
High sensitivity troponin (hsTn) assays provide an unprecedented opportunity to improve the detection and treatment of cardiac injury from coronary and non-coronary causes. They may also play a role in guiding the primary and secondary prevention of cardiovascular disease. However, to derive maximal benefit from their use, careful planning for the implementation of these new assays is required. In this manuscript, we will discuss actions that can be taken during hsTn pre-implementation, implementation and post-implementation phases. Key concepts for consideration in the pre-implementation phase include: the establishment of a multi-disciplinary implementation team; development of quality control procedures; education of clinical staff; modification of existing clinical workflow and provision of computerized decision support. Strategies for ensuring successful implementation and post-implementation phases will also be discussed.
Department of Emergency Medicine, University of Michigan Medical School , Ann Arbor, Michigan, USA.
Frederick K
FK
Korley
Cardiovascular Division and Division of Core Clinical Laboratory Services, Departments of Medicine and Laboratory Medicine and Pathology, Mayo Clinic and Medical School , Rochester, Minnesota, USA.
Allan S
AS
Jaffe
acute coronary syndrome; high sensitivity troponin; implementation
Ann Clin Biochem. 2014 Jul;51(Pt 4):476-84
24056812
J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98
22958960
Acad Emerg Med. 2014 Jul;21(7):727-35
25112512
Clin Chem. 2015 Apr;61(4):657-63
25672334
Am J Emerg Med. 2015 Dec;33(12):1790-4
26387473
Ann Emerg Med. 2016 Jul;68(1):76-87.e4
26794254
Circulation. 2015 Jun 9;131(23):2032-40
25948541
Clin Biochem. 2015 Mar;48(4-5):201-3
25204966
Eur Heart J Acute Cardiovasc Care. 2017 Feb;6(1):60-68
26772795
BMJ. 2015 Jan 21;350:g7873
25609052
Clin Chim Acta. 2014 Feb 15;429:6-7
24269504
J Am Coll Cardiol. 2015 Apr 28;65(16):1655-64
25908071
JAMA. 2011 Mar 23;305(12):1210-6
21427373
Clin Chem Lab Med. 2011 Feb;49(2):335-6
21077790
Int J Cardiol. 2013 Oct 9;168(4):3896-901
23876467
Am J Med. 2012 Dec;125(12):1205-1213.e1
23164485
Eur Heart J. 2016 Jan 14;37(3):267-315
26320110
J Am Coll Cardiol. 2014 Jun 17;63(23):2569-78
24694529
Arch Pathol Lab Med. 2009 Jan;133(1):38-43
19123734
CMAJ. 2015 May 19;187(8):E243-52
25869867
Am J Med. 2015 Aug;128(8):861-870.e4
25840034
Lancet. 2015 Dec 19;386(10012):2481-8
26454362
Biomark Med. 2014;8(8):1021-32
25343674
J Am Coll Cardiol. 2013 Apr 30;61(17):1753-8
23395074
Clin Chem. 2015 Jul;61(7):983-9
25979953
Clin Chem. 2015 Sep;61(9):1209-10
26185217
Circulation. 2013 Jan 22;127(3):e355-6
23457724
Circulation. 2014 Feb 11;129(6):625-34
24226808
Clin Chim Acta. 2014 Sep 25;436:273-5
24972004
Clin Chem. 2010 Aug;56(8):1357-9
20525763
Am Heart J. 2016 Jan;171(1):92-102.e1-5
26699605
Clin Chem. 2009 Jul;55(7):1303-6
19478023
Clin Chem. 2012 Jan;58(1):54-61
21965555
Ann Emerg Med. 2011 Feb;57(2):89-99.e2
20541284